1. Casey DE, Toenniessen LM (1983) Neuroleptic treatment in tardive dyskinesia: Can it be developed into a clinical strategy for long-term treatment? In: Ban TA, Pichot P, Poldinger LW (eds) Modern problems of pharmacopsychiatry. Karger, Basel, pp 65–79
2. Casey DE, Gerlach J, Korsgaard S (1981) Clinical pharmacological approaches to evaluating tardive dyskinesia. In: Usdin E, Dahl S, Gram LF, Lingjaerde O (eds) Clinical pharmacology in psychiatry: neuroleptic and antidepressant research. MacMillan, London, pp 369–382
3. Christensen AV (1981) Dopamine hyperactivity. Effects of neuroleptics alone and in combination with GABA agonists. In: Perris C, Struwe G, Jansson B (eds) Biological psychiatry. Elsevier, Amsterdam, pp 828–832
4. Ettigi P, Nair NPV, Lai S, Cervantes P, Guyda H (1976) Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy. J Neurol Neurosurg Psychiatry 39: 870–876
5. Fahn S (1983) Treatment of tardive dyskinesia: use of dopamine-depleting agents. Clin Neuro-pharmacol 6: 151–157